When the market gets a little sketchy, investors might tend to prefer the “blue chip” companies vs. the smaller companies due to the perceived safety in the bigger names.To isolate those bigger names, the most common method is by searching for companies with the largest market capitalization.Market cap is defined as the total dollar market value of all of a […]
By Profit Scanner for InvestorPlace MediaHealthcare has been far and away the best sector of 2015 so far — and biotech stocks are no exception.The iShares Nasdaq Biotechnology Index (ETF) (IBB) is up 9.4% in just the year-to-date; that’s about twice the return of the Nasdaq as a whole, and four-and-a-half times more than the S&P 500. And analysts at […]
Yes biotech has outperformed the S&P for years now, and yes some stocks in the group may be stretched. I also respect the market enough not to wax Pollyannish here. There will speed bumps along the way, but this powerful trend is up and it shows no signs of slowing down.Could $IBB pullback to to 280-290 and still end the […]
The new BioShares exchange traded funds offer exposure into small and mid-sized biotech stocks in what portends to be a big year in the sector.See original here:New Biotech ETFs Offer Exposure to Smaller Players in Hot SectorTagged as: amgn, bbc, big-year, biotech, etfs, exchange-traded, Finance, funds-offer, ibb, mid-sized-biotech, Personal Finance, sector, video: markets, Youtube
See original:
New Biotech ETFs Offer Exposure to […]
The biotech sector has started 2015 with the announcement of several deals. Both Kite Pharma (KITE – Snapshot Report) and Isis Pharmaceuticals (ISIS – Analyst Report) saw their share prices increasing on collaboration agreements with major companies. Meanwhile, Alkermes (ALKS – Analyst Report) has also started the year on a positive note with encouraging pipeline data.Recap of the Week’s Most […]
SummaryThere has definitely been a sector rotation out of biotech stocks and into the consumer goods names that pay high dividend yields.
Amgen remains fairly valued based on 2015 earnings estimates.
The dividend is small but investors received a 29.5% increase to the dividend in the next quarter.
The last time I analyzed Amgen Inc. (NASDAQ:AMGN) on November 25, 2014, I stated, “More […]
LONDON, November 24, 2014 /PRNewswire/ –Investor-Edge has initiated coverage on the following equities: Amgen Inc. (NASDAQ: AMGN), Merrimack Pharmaceuticals Inc. (NASDAQ: MACK), NPS Pharmaceuticals Inc. (NASDAQ: NPSP), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, November 21, 2014, the NASDAQ Composite ended at 4,712.97, […]
Market Wrap-up for Nov. 10 – 3 Sectors to Watch This WeekBy Tom Reese|November 10th, 2014
RSSA few key sectors will likely dominate the market action this week, playing a bigger-than-usual role in pushing the averages higher or lower. Here’s what investors should look out for in the coming days.1. How Will Oil Companies Hold Up?The per-barrel price of oil […]
Biotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition activities, expansion into emerging markets and ever-increasing health care spending led the sector to easily outperform the broader U.S. equity markets.Though lofty valuations and regulatory concerns did bring in some pain […]
[PR Newswire] – THOUSAND OAKS, Calif., May 12, 2014 /PRNewswire/ — Amgen today announced that four individuals who are an inspiration for others affected by cancer have been selected as Breakaway from Cancer® Champions. They will be honored as part of moreView todays social media effects on AMGNView the latest stocks trending across Twitter. Click to view dashboardSee who […]
